What does a cancer slope factor (CSF) quantify?

• A. It quantifies cancer risk per unit dose and is used to compute incremental lifetime cancer risk (ILCR = CDI × CSF).
• B. It measures LD50.
• C. It is used to derive RfD.
• D. It is unrelated to cancer risk.

Answer: (A)

The main idea is that the cancer slope factor quantifies how cancer risk changes with each unit of lifetime exposure to a carcinogen. It represents the increase in cancer probability per unit dose (per mg/kg-day) and is used to estimate lifetime cancer risk by multiplying the chronic daily intake by the CSF: ILCR = CDI × CSF. This is why it’s the appropriate measure for cancer risk assessment.

LD50 measures the dose that lethally kills 50% of a population in acute toxicity tests, which has nothing to do with cancer risk. The reference dose (RfD) is a non-cancer risk benchmark used to limit daily exposure to non-cancer effects; it’s not derived from CSF. So the CSF is specifically about cancer risk, not acute lethality or non-cancer risk.